Inhibition of TNF-α, IL-1α, and IL-1β by Pretreatment of Human Monocyte-Derived Macrophages with Menaquinone-7 and Cell Activation with TLR Agonists in Vitro

Journal of Medicinal Food

Volumn 19, Issue 7, 2016, Pages 663-669

  Pan, Min Hsiung ^a,b,c,d   Maresz, Katarzyna ^e   Lee, Pei Sheng ^d   Wu, Jia Ching ^d   Ho, Chi Tang ^f   Popko, Janusz ^g,h   Mehta, Dilip S ⁱ   Stohs, Sidney J ^j   Badmaev, Vladimir ^k,l  

^a HUANGGANG NORMAL UNIVERSITY   (China)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e International Science and Health Foundation   (Poland)

^f RUTGERS UNIVERSITY   (United States)

^g State College of Computer Science and Business Administration   (Poland)

^h MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

ⁱ Jogani Industrial Complex   (India)

^j CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^k American Medical Holdings Inc   (United States)

^l NattoPharma ASA ^*  (Norway)

more..

Author keywords

cardiovascular; inflammation; MenaQ7 Crystals; menaquinone 7; TNF a

Indexed keywords

FARNOQUINONE; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; LIPOPEPTIDE; LIPOPOLYSACCHARIDE; MACROPHAGE ACTIVATING LIPOPEPTIDE; MENAQUINONE 7; PATHOGEN ASSOCIATED MOLECULAR PATTERN; TOLL LIKE RECEPTOR AGONIST; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; IL1A PROTEIN, HUMAN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR; VITAMIN MK 7;

ARTICLE; CELL ACTIVATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; INFLAMMATION; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; AGONISTS; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; CELL LINE; DRUG EFFECTS; GENETICS;

ANTI-INFLAMMATORY AGENTS; CELL LINE; GENE EXPRESSION; HUMANS; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MACROPHAGES; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN K 2;

EID: 84979053764     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2016.0030     Document Type: Article

References (18)

1. Doherty TM, Asotra K, Fitzpatrick LA, et al.: Calcification in atherosclerosis: Bone biology and chronic inflammation at the arterial crossroads. Proc Natl Acad Sci U S A 2003;100:11201-11206
2. Ferri C, Croce G, Cofini V, et al.: C-reactive protein: Interaction with the vascular endothelium and possible role in human atherosclerosis. Curr Pharm Des 2007;13:1631-1645
3. Shea MK, Booth SL, Massaro JM, et al.: Vitamin K and vitamin D status: Associations with inflammatory markers in the Framingham Offspring Study. Am J Epidemiol 2008;167:313-320
4. Fiala M, Cribbs DH, Rosenthal M, Bernard G: Phagocytosis of amyloid-beta and inflammation: Two faces of innate immunity in Alzheimer's disease. J Alzheimers Dis 2007;11:457-463
5. Ohshima H, Tazawa H, Sylla BS, Sawa T: Prevention of human cancer by modulation of chronic inflammatory processes. Mutat Res 2005;591:110-122
6. Wei SS, Sinniah R: Adalimumab (TNF alpha Inhibitor) therapy exacerbates IgA glomerulonephritis acute renal injury and induces lupus autoantibodies in a psoriasis patient. Case Rep Nephrol 2013;2013:812781
7. Philip M, Rowley DA, Schreiber H: Inflammation as a tumor promoter in cancer induction. Semin Cancer Biol 2004;14:433-439
8. Romas E, Gillespie MT, Martin TJ: Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Bone 2002;30:340-346
9. Geleijnse JM, Vermeer C, Grobbee DE, et al.: Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: The Rotterdam Study. J Nutr 2004;134:3100-3105
10. Koziel J, Kmiecik K, Chmiest D, et al.: The role of Mcl-1 in S. aureus-induced cytoprotection of infected macrophages. Mediators Inflamm 2013;2013:427021
11. McKellar G, Madhok R, Singh G: The problem with NSAIDs: What data to believe? Curr Pain Headache Rep 2007;11:423-427
12. Angel K, Provan SA, Fagerhol MK, Mowinckel P, Kvien TK, Atar D: Effect of 1-year anti-TNF-alpha therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: Acontrolled study.AmJ Hypertens 2012;25:644-650
13. Kurnatowska I, Grzelak P, Masajtis-Zagajewska A, et al.: Effect of vitamin K2 on progression of atherosclerosis and vascular calcification in nondialyzed patients with chronic kidney disease stages 3-5. Pol Arch Med Wewn 2015;125:631-640
14. Zaragatski E, Grommes J, Schurgers LJ, et al.: Vitamin K antagonism aggravates chronic kidney disease-induced neointimal hyperplasia and calcification in arterialized veins: Role of vitamin K treatment? Kidney Int 2015. DOI:10.1038/ki. 2015.298
15. Knapen MH, Braam LA, Drummen NE, Bekers O, Hoeks AP, Vermeer C: Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial. Thromb Haemost 2015;113:1135-1144
16. McCarty S, Frishman W: Interleukin 1beta: A proinflammatory target for preventing atherosclerotic heart disease. Cardiol Rev 2014;22:176-181
17. Theuwissen E, Cranenburg EC, Knapen MH, et al.: Low-dose menaquinone-7 supplementation improved extra-hepatic vitamin K status, but had no effect on thrombin generation in healthy subjects. Br J Nutr 2012;108:1652-1657
18. Okuyama H, Langsjoen PH, Hamazaki T, et al.: Statins stimulate atherosclerosis and heart failure: Pharmacological mechanisms. Expert Rev Clin Pharmacol 2015;8:189-199